Hostname: page-component-848d4c4894-2xdlg Total loading time: 0 Render date: 2024-06-24T15:07:16.811Z Has data issue: false hasContentIssue false
  • English
  • Français

Biomarkers detect involvement of acute myocardial injury in a paediatric haemolytic–uraemic syndrome patient

Published online by Cambridge University Press:  03 February 2016

Daniel Palanca Arias ,
Marta López Ramón  and
Lorenzo Jiménez Montañés
Daniel Palanca Arias*
Affiliation:
Pediatric Intensive Care Unit, Department of Pediatrics, Hospital Infantil Universitario Miguel Servet, Zaragoza, Spain Pediatric Cardiology Unit, Department of Pediatrics, Hospital Infantil Universitario Miguel Servet, Zaragoza, Spain
Marta López Ramón
Affiliation:
Pediatric Cardiology Unit, Department of Pediatrics, Hospital Infantil Universitario Miguel Servet, Zaragoza, Spain
Lorenzo Jiménez Montañés
Affiliation:
Pediatric Cardiology Unit, Department of Pediatrics, Hospital Infantil Universitario Miguel Servet, Zaragoza, Spain
*
Correspondence to: D. Palanca Arias, PhD, Pediatric Cardiology and Pediatric Intensive Care Unit, Department of Pediatrics, Hospital Infantil Universitario Miguel Servet, Paseo Isabel La Católica, Vía Hispanidad, Bloque 10, 3V. 50009 Zaragoza, Spain. Tel: +34 620 44 65 87; Fax: 976091601; E-mail: danielpalanca@hotmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Although extrarenal manifestations of haemolytic–uraemic syndrome are not frequent, myocardial dysfunction should be given special consideration because of the importance of proper early haemodynamic management and potential complications. We report the case of a 21-month-old child with haemolytic–uraemic syndrome who developed clinical signs of poor myocardial function with depressed myocardial function noted by bedside echocardiography and significant elevation of biomarkers. Early intervention and supportive treatment for the patient were crucial during the acute phase of cardiac failure, and repeated monitoring of biomarkers and ecocardiography were useful diagnostic tools that provided relevant information throughout the patient’s evolution.

Keywords

Haemolytic–uraemic syndromeechocardiographymyocardial ischaemiadilated cardiomyopathybiomarkers
Type
Brief Reports
Information
Cardiology in the Young , Volume 26 , Issue 5 , June 2016 , pp. 983 - 986
Check for updates
Copyright
© Cambridge University Press 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Mohammed, J, Filler, G, Price, A, Sharma, AP. Cardiac tamponade in diarrhoea-positive haemolytic uraemic syndrome. Nephrol Dial Transplant 2009; 24: 679–681.Google Scholar
2. Choi, EY, Kwon, HM, Yoon, YW, Kim, D, Kim, HS. Assessment of extent of myocardial ischemia in patients with non-ST elevation acute coronary syndrome using serum B-type natriuretic peptide level. Yonsei Med J 2004; 45: 255–262.Google Scholar
3. Arakawa, N, Nakamura, M, Aoki, H, Hiramori, K. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology 1994; 85: 334–340.CrossRefGoogle ScholarPubMed
4. Antman, EM, Cohen, M, Bernink, PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000; 284: 835–842.CrossRefGoogle Scholar
5. Askiti, V, Hendrickson, K, Fish, AJ, Braunlin, E, Sinaiko, AR. Troponin I levels in a hemolytic uremic syndrome patient with severe cardiac failure. Pediatr Nephrol 2004; 19: 345–348.Google Scholar
6. Tobias, JD. Hemolytic-uremic syndrome and myocardial dysfunction in a 9-month-old boy. Paediatr Anaesth 2007; 17: 584–587.CrossRefGoogle Scholar
7. Machol, K, Vivante, A, Rubinsthein, M, Dekel, B, Danieli, J, Paret, G. Keeping the heart in mind when managing hemolytic: uremic syndrome. Isr Med Assoc J 2011; 13: 446–447.Google Scholar
8. Poulton, J, Taylor, CM, De Giovanni, JV. Dilated cardiomyopathy associated with haemolytic uraemic syndrome. Br Heart J 1987; 57: 181–183.Google Scholar